Drug Repositioning in Glioblastoma: A Pathway Perspective

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2018.00218
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

Drug Repositioning: A Faster Path to Drug Discovery

Advances in Pharmacoepidemiology & Drug Safety
2012English

Drug Repositioning of Mevalonate Pathway Inhibitors as Antitumor Agents for Ovarian Cancer

Oncotarget
Oncology
2017English

Corrigendum: Rational Drug Repositioning by Medical Genetics

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2014English

A Multilayer Network Approach for Guiding Drug Repositioning in Neglected Diseases

PLoS Neglected Tropical Diseases
PharmacologyPublic HealthEnvironmentalToxicologyInfectious DiseasesPharmaceuticsOccupational Health
2016English

Application of Artificial Intelligence for Drug Repositioning

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer’s Disease

Frontiers in Pharmacology
Pharmacology
2020English

Mining Integrated Semantic Networks for Drug Repositioning Opportunities

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2016English

Computational and Practical Aspects of Drug Repositioning

Assay and Drug Development Technologies
Drug DiscoveryMolecular Medicine
2015English

Mining Integrated Semantic Networks for Drug Repositioning Opportunities

2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy